The relationship between CYP4A11 and human hypertension

Journal of Hypertension

Volumn 26, Issue 8, 2008, Pages 1712-1714

  Elijovich, Fernando ^a,b   Laffer, Cheryl L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME P450 4A11; CYTOCHROME P450 4A12; UNCLASSIFIED DRUG; CYP4A11 PROTEIN, HUMAN; CYTOCHROME P450;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; ENZYME REGULATION; ESSENTIAL HYPERTENSION; GENE OVEREXPRESSION; HUMAN; HYPERTENSION; LETTER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETICS; HAPLOTYPE; NOTE;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HAPLOTYPES; HUMANS; HYPERTENSION;

EID: 51549097223     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283000504     Document Type: Letter

References (10)

1. Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, et al. A haplotype of the CYP4A11. gene associated with essential hypertension in Japanese men. J Hypertens 2008; 26:453-461.
2. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, et al. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 2001; 98:5211-5216.
3. Nakagawa K, Holla VR, Wie Y, Wang WH, Gatica A, Wei S, et al. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10. gene and kidney epithelial sodium channel. JClin Invest 2006; 116:1696- 1702.
4. Gainer JV, Bellamine A, Dawson EP, Womble KE, Grant SW, Wang Y, et al. Functional variant ofCYP4A11. 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005; 111. :63-69.
5. Mayer B, Lieb W, Gotz A, Konig IR, Aherrahrou Z, Theimig A, et al. Association of the T8590C polymorphism of CYP4A11. with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 2005; 46:766-771.
6. Laffer CL, Laniado-Schwartzman M, Wang MH, Nasjletti A, Elijovich F. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension. Circulation 2003;107:574-578.
7. Laffer CL, Gainer JV, Waterman MR, Capdevila JH, Laniado-Schwartzman M, Nasjletti A, et al. The T8590C polymorphism of CYP4A11. and 20-hydroxyeicosatetraenoic acid in essential hypertension. Hypertension 2008; 51. :767-772.
8. Roman RJ, Alonso-Galicia M, Wilson TW. Renal P450. metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens 1997; 10:S63-S67.
9. Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, Croft KD. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 2004; 110:438-443.
10. Su P, Kaushal KM, Kroetz DL. Inhibition of renal arachidonic acid omega- hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol 1998; 275:R426-R438.